S

Sunesis Pharmaceuticals, Inc.

42 employees

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

1987

Funding rounds raised

Total raised

$60M

from 30 investors over 30 rounds

S

Sunesis Pharmaceuticals, Inc. raised $15M on April 1, 2016

Investors: Bridge Bank

S

Sunesis Pharmaceuticals, Inc. raised $44M on April 7, 2009

Investors: Nextech Invest, Opus Point Partners, Merlin Nexus, Alta Partners, Bay City Capital and Venrock

S

Sunesis Pharmaceuticals, Inc. raised $14M on September 16, 2004

Investors: Mayfield Fund, Credit Suisse First Boston, Abingworth, Biogen Idec and Warburg Pincus LLC

S

Sunesis Pharmaceuticals, Inc. raised $6M on December 20, 2002

Investors: Mayfield Fund, Credit Suisse First Boston, Abingworth and Warburg Pincus LLC

S

Sunesis Pharmaceuticals, Inc. raised $60M on July 11, 2000

Investors: Mayfield Fund, Credit Suisse First Boston, Venrock, Abingworth and Warburg Pincus LLC

S

Sunesis Pharmaceuticals, Inc. raised $25M on December 6, 1999

Investors: Abingworth, Sky Ventures, Venrock, Mayfield Fund and Warburg Pincus LLC

S

Sunesis Pharmaceuticals, Inc. raised undisclosed on December 1, 1998

Investors: Abingworth, Mayfield Fund, Sky Ventures and Venrock

FAQ